BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang J, Wu Z, Yang L, Jeong JH, Zhu Y, Lu J, Wang B, Wang N, Wang Y, Shen K, Li R. Characterization of Kinesin Family Member 2C as a Proto-Oncogene in Cervical Cancer. Front Pharmacol 2021;12:785981. [PMID: 35153749 DOI: 10.3389/fphar.2021.785981] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang P, Gao H, Ye C, Yan R, Yu L, Xia C, Yang D. Large-Scale Transcriptome Data Analysis Identifies KIF2C as a Potential Therapeutic Target Associated With Immune Infiltration in Prostate Cancer. Front Immunol 2022;13:905259. [PMID: 35720323 DOI: 10.3389/fimmu.2022.905259] [Reference Citation Analysis]
2 Zhang X, Li Y, Hu P, Xu L, Qiu H. KIF2C is a Biomarker Correlated With Prognosis and Immunosuppressive Microenvironment in Human Tumors. Front Genet 2022;13:891408. [DOI: 10.3389/fgene.2022.891408] [Reference Citation Analysis]